AC Immune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.About ACIU
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU Key Statistics
Stock Snapshot
As of today, AC Immune(ACIU) shares are valued at $3.31. The company's market cap stands at 326.51M, with a P/E ratio of -3.91.
On 2025-12-17, AC Immune(ACIU) stock traded between a low of $3.12 and a high of $3.45. Shares are currently priced at $3.31, which is +6.1% above the low and -4.1% below the high.
The AC Immune(ACIU)'s current trading volume is 692.47K, compared to an average daily volume of 2.6M.
In the last year, AC Immune(ACIU) shares hit a 52-week high of $4.00 and a 52-week low of $1.43.
In the last year, AC Immune(ACIU) shares hit a 52-week high of $4.00 and a 52-week low of $1.43.
ACIU News
AC Immune SA (NASDAQ:ACIU) on Thursday released interim safety and efficacy results from the Phase 2 VacSYn trial of its anti-alpha-synuclein (a-syn) active imm...
AC Immune (ACIU) added ~30% in the premarket on Thursday after the Swiss biotech announced positive initial results from a mid-stage trial for ACI-7104.056, an...
AC Immune (ACIU) announced positive interim safety and efficacy results from the Phase 2 VacSYn trial of its wholly-owned anti-alpha-synuclein active immunother...
More ACIU News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Advertisement Key Insights Significant control over AC Immune by retail investors implies that the general public has more power to influence management and g...
